Opaganib Protects Against High-Fat Diet-Induced Hypercholesterolemia and Liver Steatosis in Mice
Diabetes, Metabolic Syndrome and Obesity · 2026-10 · Volume 19 · 1-18
DOI: 10.2147/dmso.s617948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-10. Verfasst von Lynn W Maines und 3 weiteren Autor:innen. Beteiligte Einrichtung: Apogee Biotechnology Corporation, Hummelstown, PA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Apogee Biotechnology Corporation, Hummelstown, PA, USA.
ORCID-Profile: Charles D Smith
Zitieren
APA
Maines, L. W., Keller, S. N., Smith, R. A., & Smith, C. D. (2026). Opaganib Protects Against High-Fat Diet-Induced Hypercholesterolemia and Liver Steatosis in Mice. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-18. https://doi.org/10.2147/dmso.s617948
Vancouver
Maines LW, Keller SN, Smith RA, Smith CD. Opaganib Protects Against High-Fat Diet-Induced Hypercholesterolemia and Liver Steatosis in Mice. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-18. doi:10.2147/dmso.s617948
BibTeX
@article{Maines2026,
author = {Maines, Lynn W and Keller, Staci N and Smith, Ryan A and Smith, Charles D},
title = {Opaganib Protects Against High-Fat Diet-Induced Hypercholesterolemia and Liver Steatosis in Mice},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--18},
doi = {10.2147/dmso.s617948}
}
EUVIMED